VIDEO: Ibalizumab continues to suppress MDR HIV after 48 weeks
5 monthes ago - By Healio
SAN DIEGO - In this video, Brinda Emu, MD, assistant professor of medicine at Yale University, reviews 48-week data of a phase 3 trial evaluating the safety and efficacy of ibalizumab in patients with multidrug-resistant HIV.
Ibalizumab is a long-acting humanized monoclonal antibody administered intravenously every 2 weeks to patients on a failing HIV drug regimen. It is currently undergoing regulatory review in the United States and represents the first new class of antiretrovirals to be submitted for approval in the past 10 years, according to Emu.
Data presented at IDWeek showed that
Read more ...
Search by Tags
The headlines of Master Doctor
Two New Devices Help Fight Stress Among Adolescents
Adolescents experience stress and have disturbed sleep. However, EnergyPod and SleepWing devices help reduce stress and improve sleep, reveals a new study.
Zoonotic TB Survivor Resolves to Make Her Community TB-free: World...
At the first-ever WHO global ministerial conference on ending TB in the Sustainable Development Era: A Multisectoral Response, Timpiyian Leseni tells us her story of how she...
Cocaine and Heroin Use may be Detected from Fingerprints
Fingerprints show enhanced levels of cocaine, heroin, and their respective metabolites in patients who testified to taking the substances, compared with the population of naive...
Dental Sensors Can Help Track What You Eat
Dental sensors can help keep track of all the unhealthy treats you should not have eaten by real-time data monitoring.
Lower radiotherapy dose is good as targeted breast cancer treatment
Thousands of women who have radiotherapy for breast cancer could be spared severe side-effects after scientists found that targeted treatments or lower doses were just as...
Bad lifestyles cause 2,500 UK cancer cases a week
Almost four in ten of all cancers could be avoided by switching to a healthier diet, doing more exercise and giving up smoking, according to Cancer Research UK.
New Culprit in Pancreatic Cancer Progression Identified
Gut microbiome was associated with pancreatic cancer progression. Immunotherapy can be effective when microbiome is targeted in pancreatic cancer patients, which can prevent...
False Memories in Older Adults may be Induced by Inability to Remember Details
Older adults who often forget the details are also found to have the problem of misremembering, finds a new study.
Beetroot: The New Alzheimer's Superfood
Betanin compound that gives the vegetable its distinctive red colour could help prevent Alzheimer's disease. This new finding could lead to the development of drugs for...
Vitamin D Deficiency During Pregnancy may Increase Autism Risk in Offspring
Maternal vitamin D deficiency may increase autism risk in children later in life, finds new study. Autism is a lifelong condition that ranges in severity and impacts on how...